Geode Capital Management, LLC Pds Biotechnology Corp Transaction History

Geode Capital Management, LLC

$1.07 Trillion
Q1 2024

A detailed history of Geode Capital Management, LLC transactions in Pds Biotechnology Corp stock. As of the latest transaction made, Geode Capital Management, LLC holds 654,185 shares of PDSB stock, worth $1.93 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

654,185

Previous 633,204 3.31%

Holding current value

$1.93 Million

Previous $3.15 Million 17.7%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$3.85 - $6.59 $80,776 - $138,264	20,981 Added 3.31%	654,185 $2.59 Million
Q4 2023 Feb 13, 2024	BUY	$3.95 - $6.58 $125,783 - $209,533	31,844 Added 5.3%	633,204 $3.15 Million
Q3 2023 Nov 13, 2023	BUY	$4.8 - $6.4 $115,036 - $153,382	23,966 Added 4.15%	601,360 $3.04 Million
Q2 2023 Aug 11, 2023	BUY	$5.03 - $9.9 $1.43 Million - $2.82 Million	285,141 Added 97.57%	577,394 $2.9 Million
Q1 2023 May 15, 2023	BUY	$5.68 - $11.99 $71,920 - $151,817	12,662 Added 4.53%	292,253 $1.8 Million

Q4 2022 Feb 13, 2023	BUY	$4.92 - $13.2 $44,949 - $120,595	9,136 Added 3.38%	279,591 $3.69 Million
Q3 2022 Nov 14, 2022	BUY	$3.04 - $5.79 $78,021 - $148,600	25,665 Added 10.48%	270,455 $803,000
Q2 2022 Aug 12, 2022	BUY	$3.05 - $6.68 $40,787 - $89,331	13,373 Added 5.78%	244,790 $893,000
Q1 2022 May 13, 2022	BUY	$4.78 - $8.43 $111,374 - $196,419	23,300 Added 11.2%	231,417 $1.43 Million
Q4 2021 Feb 11, 2022	BUY	$7.76 - $14.35 $185,254 - $342,577	23,873 Added 12.96%	208,117 $1.69 Million
Q3 2021 Nov 12, 2021	BUY	$9.33 - $17.08 $58,956 - $107,928	6,319 Added 3.55%	184,244 $2.75 Million
Q2 2021 Aug 13, 2021	BUY	$4.35 - $12.86 $33,782 - $99,870	7,766 Added 4.56%	177,925 $2.23 Million
Q1 2021 May 12, 2021	BUY	$2.28 - $6.81 $177,637 - $530,573	77,911 Added 84.46%	170,159 $774,000
Q3 2020 Nov 13, 2020	BUY	$1.67 - $4.67 $13,926 - $38,943	8,339 Added 9.94%	92,248 $214,000
Q2 2020 Aug 13, 2020	BUY	$0.65 - $2.6 $42,752 - $171,009	65,773 Added 362.67%	83,909 $168,000
Q2 2019 Aug 14, 2019	BUY	$5.44 - $8.68 $34,533 - $55,100	6,348 Added 53.85%	18,136 $108,000
Q1 2019 May 14, 2019	BUY	$6.8 - $10.08 $80,158 - $118,823	11,788 New	11,788 $87,000

Others Institutions Holding PDSB

# of Institutions

Shares Held

7.53M

Call Options Held

140K

Put Options Held

318K

View Full List

About PDS Biotechnology Corp

Ticker PDSB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,458,700
Market Cap $84M
Description
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...

More about PDSB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Pds Biotechnology Corp Transaction History